• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structure and Immune Recognition of the HIV Glycan Shield.HIV聚糖屏蔽层的结构与免疫识别
Annu Rev Biophys. 2018 May 20;47:499-523. doi: 10.1146/annurev-biophys-060414-034156. Epub 2018 Mar 29.
2
The HIV glycan shield as a target for broadly neutralizing antibodies.作为广泛中和抗体靶点的HIV聚糖屏蔽层
FEBS J. 2015 Dec;282(24):4679-91. doi: 10.1111/febs.13530. Epub 2015 Oct 23.
3
Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.去除保守的CD4结合位点近端聚糖导致的HIV-1包膜三聚体结构和抗原性变化
J Virol. 2016 Sep 29;90(20):9224-36. doi: 10.1128/JVI.01116-16. Print 2016 Oct 15.
4
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.糖基工程化 HIV-1 Env 产生“超级充电”和“杂交”聚糖,以提高中和抗体的效力、广度和饱和度。
PLoS Pathog. 2018 May 2;14(5):e1007024. doi: 10.1371/journal.ppat.1007024. eCollection 2018 May.
5
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.膜锚定HIV-1包膜糖蛋白三聚体与可溶性gp140糖基化谱的比较分析
J Virol. 2015 Aug;89(16):8245-57. doi: 10.1128/JVI.00628-15. Epub 2015 May 27.
6
Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.HIV-1包膜三聚体的功能稳定性影响其顶端对广泛中和抗体的可及性。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01216-17. Print 2017 Dec 15.
7
Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.人免疫缺陷病毒1型表面抗原上的N-连接聚糖在调节病毒对针对受体和共受体结合位点的广泛中和抗体敏感性方面的保守作用。
J Virol. 2015 Oct 28;90(2):829-41. doi: 10.1128/JVI.02321-15. Print 2016 Jan 15.
8
Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.酵母糖蛋白引发的抗体可识别HIV-1病毒体,并有效中和具有高甘露糖N-聚糖的病毒体。
Vaccine. 2015 Sep 22;33(39):5140-7. doi: 10.1016/j.vaccine.2015.08.012. Epub 2015 Aug 13.
9
Glycans in HIV-1 vaccine design - engaging the shield.HIV-1 疫苗设计中的糖链 - 攻克保护罩。
Trends Microbiol. 2022 Sep;30(9):866-881. doi: 10.1016/j.tim.2022.02.004. Epub 2022 Mar 9.
10
Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.三聚体顶端的结构约束使 HIV-1 包膜保持在封闭的、抗体保护的构象。
mBio. 2018 Dec 11;9(6):e00955-18. doi: 10.1128/mBio.00955-18.

引用本文的文献

1
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2510163122. doi: 10.1073/pnas.2510163122. Epub 2025 Aug 11.
2
Surface Plasmon Resonance for the Interaction of Capsular Polysaccharide (CPS) With KpACE.用于荚膜多糖(CPS)与KpACE相互作用的表面等离子体共振
Bio Protoc. 2025 Jun 20;15(12):e5346. doi: 10.21769/BioProtoc.5346.
3
Identification of SARS-CoV-2-binding lectins on a commercial lectin array.在商业凝集素芯片上鉴定严重急性呼吸综合征冠状病毒2(SARS-CoV-2)结合凝集素
Sci Rep. 2025 Jul 1;15(1):21687. doi: 10.1038/s41598-025-01903-5.
4
Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy.中和抗体:在免疫反应及基于病毒载体的基因治疗中的作用
Int J Mol Sci. 2025 May 29;26(11):5224. doi: 10.3390/ijms26115224.
5
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
bioRxiv. 2025 May 27:2025.05.22.655646. doi: 10.1101/2025.05.22.655646.
6
Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.与从自然暴露个体中分离出的强效单克隆抗体复合的全长Pfs48/45的结构解析
Nat Struct Mol Biol. 2025 May 22. doi: 10.1038/s41594-025-01532-6.
7
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.人类免疫缺陷病毒1型疫苗研究的进展与挑战:全面综述
Vaccines (Basel). 2025 Jan 31;13(2):148. doi: 10.3390/vaccines13020148.
8
Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging.使用双报告基因传感器细胞和活细胞成像对菌株特异性HIV-1 Vif活性进行单细胞描绘。
J Virol. 2025 Mar 18;99(3):e0157924. doi: 10.1128/jvi.01579-24. Epub 2025 Feb 25.
9
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.在HIV-1包膜构象可塑性的背景下评估广谱中和抗体(bnAb)的效力。
PLoS Pathog. 2025 Jan 21;21(1):e1012825. doi: 10.1371/journal.ppat.1012825. eCollection 2025 Jan.
10
Humoral Immunity Profiling to Pandemic and Bat-Derived Coronavirus Variants: A Geographical Comparison.针对大流行和蝙蝠源性冠状病毒变种的体液免疫分析:地域比较
Adv Sci (Weinh). 2025 Jan;12(1):e2403503. doi: 10.1002/advs.202403503. Epub 2024 Oct 29.

本文引用的文献

1
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.一种在体内能结合多种广泛中和抗体前体的类天然HIV-1包膜三聚体的设计与晶体结构
J Exp Med. 2017 Sep 4;214(9):2573-2590. doi: 10.1084/jem.20161160. Epub 2017 Aug 28.
2
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.一种合理设计的预融合 MERS-CoV 刺突抗原的免疫原性和结构。
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357. doi: 10.1073/pnas.1707304114. Epub 2017 Aug 14.
3
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike.开放和封闭结构揭示了HIV-1包膜刺突中的变构和柔韧性。
Nature. 2017 Jul 20;547(7663):360-363. doi: 10.1038/nature23010. Epub 2017 Jul 12.
4
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers.降低可溶性、类天然HIV-1包膜糖蛋白三聚体上V3区的抗原性和免疫原性。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00677-17. Print 2017 Aug 1.
5
Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.在螺旋-卷曲转变处进行甘氨酸取代有助于稳定的C亚型HIV包膜糖蛋白的结构测定。
Immunity. 2017 May 16;46(5):792-803.e3. doi: 10.1016/j.immuni.2017.04.014.
6
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.病毒样颗粒鉴定出一种缺乏突出环的HIV V1V2顶端结合中和抗体。
Immunity. 2017 May 16;46(5):777-791.e10. doi: 10.1016/j.immuni.2017.04.011.
7
CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface.流感病毒受体结合位点抗体 - 抗原界面的冷冻电镜结构
J Mol Biol. 2017 Jun 16;429(12):1829-1839. doi: 10.1016/j.jmb.2017.05.011. Epub 2017 May 12.
8
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.HIV-1聚糖屏蔽对抗体诱导影响的定量分析。
Cell Rep. 2017 Apr 25;19(4):719-732. doi: 10.1016/j.celrep.2017.04.013.
9
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.一种广泛中和抗体通过长的、刚性化的阴离子β-发夹结构靶向动态HIV包膜三聚体顶端。
Immunity. 2017 Apr 18;46(4):690-702. doi: 10.1016/j.immuni.2017.03.017.
10
Structural principles controlling HIV envelope glycosylation.控制HIV包膜糖基化的结构原理。
Curr Opin Struct Biol. 2017 Jun;44:125-133. doi: 10.1016/j.sbi.2017.03.008. Epub 2017 Mar 29.

HIV聚糖屏蔽层的结构与免疫识别

Structure and Immune Recognition of the HIV Glycan Shield.

作者信息

Crispin Max, Ward Andrew B, Wilson Ian A

机构信息

Centre for Biological Sciences and Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom; email:

Department of Integrative Structural and Computational Biology, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, International AIDS Vaccine Initiative Neutralizing Antibody Center, and Collaboration for AIDS Vaccine Discovery, The Scripps Research Institute, La Jolla, California 92037, USA; email:

出版信息

Annu Rev Biophys. 2018 May 20;47:499-523. doi: 10.1146/annurev-biophys-060414-034156. Epub 2018 Mar 29.

DOI:10.1146/annurev-biophys-060414-034156
PMID:29595997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6163090/
Abstract

Vaccine design efforts against the human immunodeficiency virus (HIV) have been greatly stimulated by the observation that many infected patients eventually develop highly potent broadly neutralizing antibodies (bnAbs). Importantly, these bnAbs have evolved to recognize not only the two protein components of the viral envelope protein (Env) but also the numerous glycans that form a protective barrier on the Env protein. Because Env is heavily glycosylated compared to host glycoproteins, the glycans have become targets for the antibody response. Therefore, considerable efforts have been made in developing and validating biophysical methods to elucidate the complex structure of the Env-spike glycoprotein, with its combination of glycan and protein epitopes. We illustrate here how the application of robust biophysical methods has transformed our understanding of the structure and function of the HIV Env spike and stimulated innovation in vaccine design strategies that takes into account the essential glycan components.

摘要

观察发现许多感染人类免疫缺陷病毒(HIV)的患者最终会产生高效的广谱中和抗体(bnAbs),这极大地推动了针对该病毒的疫苗设计工作。重要的是,这些bnAbs不仅进化到能够识别病毒包膜蛋白(Env)的两种蛋白质成分,还能识别在Env蛋白上形成保护屏障的众多聚糖。由于与宿主糖蛋白相比,Env高度糖基化,聚糖已成为抗体反应的靶点。因此,人们在开发和验证生物物理方法以阐明Env刺突糖蛋白的复杂结构(其聚糖和蛋白质表位的组合)方面付出了巨大努力。我们在此说明强大的生物物理方法的应用如何改变了我们对HIV Env刺突的结构和功能的理解,并激发了考虑到基本聚糖成分的疫苗设计策略的创新。